Skip to main content
. 2020 Jul 24;2(2):fcaa110. doi: 10.1093/braincomms/fcaa110

Table 1.

Demographic and clinical profile of HDGEC and HC participants

HDGEC = 42 Control = 36 P/χ2 value
Gender M:F 22:20 15:21 0.345
Age (years) M (SD) 50.16 (12.14) 50.55 (13.90) 0.948
Range 26–75 24–69
UHDRS–TMS M (SD) 9.21 (12.71)
Range 0–41
UHDRS–TFC M (SD) 10.90 (2.64)
Range 6–13
Disease duration M (SD) 5.06 (3.23)
(years after diagnosis) Range 1–13
CAG length M (SD) 41.26 (1.80)
Range 38–46
CAPS M (SD) 0.88 (0.25)
Range 0.32–1.40
Years of education M (SD) 14.61 (2.94) 14.83 (3.20) 0.461
Range 8–21 9–23
Estimated IQ M (SD) 104.04 (6.99) 106.14 (6.43) 0.171
Range 87–115 89–117
GIHAQ M (SD) 21.47 (25.44) 15.81 (21.33) 0.294
Range 0–119 0–116
CESD-R M (SD) 10.92 (10.45) 7.06 (7.75) 0.071
Range 0–43 0–31

CAPS: scaled CAG-age product score (for premanifest HDGECs only); estimated intelligence quotient (IQ) calculated by Wechsler Test of Adult Reading; CESD-R: Center for Epidemiologic Studies Depression Scale-Revised (range: 0–80); F: female; GIHAQ: Gastrointestinal Health Appraisal Questionnaire (range: 0–280); M: male; TFC: Total Functional Capacity (range: 0–13); disease duration is for manifest HDGECs only; TMS: Total Motor Score (range: 0–124). P/χ2 value signifies probability value between groups, using independent samples t-tests or Chi-squared test (χ2 for gender).